Skip to main content
. 2020 Feb 27;15(2):e0219412. doi: 10.1371/journal.pone.0219412

Fig 1. Relative expression of serum miR-379 in NAFLD patients.

Fig 1

A: serum miR-379 expression level between NAFLD and normal control. B: serum miR-379 expression level between NAFL, NASH. C: serum miR-379 expression level between NAFLD early stage, advanced stage and normal control. NAFLD early stage was defined as Brunt fibrosis stage 0 or 1, and advanced stage was defined as Brunt fibrosis stage 2 to 4. Value data are expressed as the mean ± standard deviation. Quantitative real-time PCR (qRT-PCR) was used to examine miRNA levels. All qRT-PCR data were normalized to that for serum miR-16, and fold-change was calculated relative to data from normal controls. *p < 0.05.